Effectiveness and safety of infliximab combined with leflunomide in chronic polyarthritis

Clin Exp Rheumatol. 2004 Nov-Dec;22(6):790.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects
  • Antirheumatic Agents / administration & dosage*
  • Antirheumatic Agents / adverse effects
  • Arthritis / drug therapy*
  • Chronic Disease
  • Drug Therapy, Combination
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / adverse effects
  • Infliximab
  • Isoxazoles / administration & dosage*
  • Isoxazoles / adverse effects
  • Leflunomide

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunosuppressive Agents
  • Isoxazoles
  • Infliximab
  • Leflunomide